Inhibitory evaluation of oligonol on α-glucosidase, protein tyrosine phosphatase 1B, cholinesterase, and β-secretase 1 related to diabetes and Alzheimer's disease

被引:15
作者
Choi, Jae Sue [1 ]
Bhakta, Himanshu Kumar [1 ]
Fujii, Hajime [2 ]
Min, Byung-Sun [3 ]
Park, Chan Hum [3 ]
Yokozawa, Takako [4 ]
Jung, Hyun Ah [5 ]
机构
[1] Pukyong Natl Univ, Dept Food & Life Sci, Busan 608737, South Korea
[2] Amino Up Chem Co Ltd, Sapporo, Hokkaido, Japan
[3] Catholic Univ Daegu, Coll Pharm, Gyeongbuk 712702, South Korea
[4] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan
[5] Chonbuk Natl Univ, Dept Food Sci & Human Nutr, Jeonju 561756, South Korea
关键词
Oligonol; Anti-diabetic activity; Anti-Alzheimer activity; Kinetics; LYCHEE FRUIT; OXIDATIVE STRESS; INSULIN ACTION; DAMAGE; ACETYLCHOLINESTERASE; POLYPHENOLS; TOXICITY; MELLITUS;
D O I
10.1007/s12272-015-0682-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oligonol is a low-molecular-weight form of polyphenol that is derived from lychee fruit extract and contains catechin-type monomers and oligomers of proanthocyanidins. This study investigates the anti-diabetic activities of oligonol via alpha-glucosidase and human recombinant protein tyrosine phosphatase 1B (PTP1B) assays, as well as its anti-Alzheimer activities by evaluating the ability of this compound to inhibit acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1). Oligonol exhibited potent concentration-dependent anti-diabetic activities by inhibiting alpha-glucosidase and PTP1B with IC50 values of 23.14 A mu g/mL and 1.02 A mu g/mL, respectively. Moreover, a kinetics study revealed that oligonol inhibited alpha-glucosidase (K (i) = 22.36) and PTP1B (K (i) = 8.51) with characteristics typical of a mixed inhibitor. Oligonol also displayed potent concentration-dependent inhibitory activity against AChE and BChE with IC50 values of 4.34 A mu g/mL and 2.07 A mu g/mL, respectively. However, oligonol exhibited only marginal concentration-dependent BACE1 inhibitory activity with an IC50 value of 130.45 A mu g/mL. A kinetics study revealed mixed-type inhibition against AChE (K (i) = 4.65) and BACE1 (K (i) = 58.80), and noncompetitive-type inhibition against BChE (K (i) = 9.80). Furthermore, oligonol exhibited dose-dependent inhibitory activity against peroxynitrite (ONOO-)-mediated protein tyrosine nitration. These results indicate that oligonol has strong preventative potential in diabetes mellitus and in Alzheimer's disease.
引用
收藏
页码:409 / 420
页数:12
相关论文
共 49 条
[31]   Treatment with oligonol, a low-molecular polyphenol derived from lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid metabolism [J].
Noh, Jeong Sook ;
Park, Chan Hum ;
Yokozawa, Takako .
BRITISH JOURNAL OF NUTRITION, 2011, 106 (07) :1013-1022
[32]   Hypolipidaemic and antioxidative effects of oligonol, a low-molecular-weight polyphenol derived from lychee fruit, on renal damage in type 2 diabetic mice [J].
Noh, Jeong Sook ;
Kim, Hyun Young ;
Park, Chan Hum ;
Fujii, Hajime ;
Yokozawa, Takako .
BRITISH JOURNAL OF NUTRITION, 2010, 104 (08) :1120-1128
[33]  
Nonaka GI, International Patent Application, Patent No. [WO/2004/103988 A1, 2004103988]
[34]   Oligonol, A New Lychee Fruit-derived Low-molecular Form of Polyphenol, Enhances Lipolysis in Primary Rat Adipocytes through Activation of the ERK1/2 pathway [J].
Ogasawara, Junetsu ;
Kitadate, Kentaro ;
Nishioka, Hiroshi ;
Fujii, Hajime ;
Sakurai, Takuya ;
Kizaki, Takako ;
Izawa, Tetsuya ;
Ishida, Hitoshi ;
Ohno, Hideki .
PHYTOTHERAPY RESEARCH, 2009, 23 (11) :1626-1633
[35]   Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, attenuates gluco-lipotoxicity-mediated renal disorder in type 2 diabetic db/db mice [J].
Park, Chan Hum ;
Noh, Jeong Sook ;
Fujii, Hajime ;
Roh, Seong-Soo ;
Song, Yeong-Ok ;
Choi, Jae Sue ;
Chung, Hae Young ;
Yokozawa, Takako .
DRUG DISCOVERIES AND THERAPEUTICS, 2015, 9 (01) :13-22
[36]   Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model [J].
Park, Jae-Yeo ;
Kim, Younghwa ;
Im, Jee Ae ;
Lee, Hyangkyu .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
[37]   Signaling pathways in insulin action: molecular targets of insulin resistance [J].
Pessin, JE ;
Saltiel, AR .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) :165-169
[38]   Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease [J].
Rao, Allam A. ;
Sridhar, Gumpeny R. ;
Das, Undurti N. .
MEDICAL HYPOTHESES, 2007, 69 (06) :1272-1276
[39]   Oxidative Stress in Diabetes and Alzheimer's Disease [J].
Reddy, V. Prakash ;
Zhu, Xiongwei ;
Perry, George ;
Smith, Mark A. .
JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) :763-774
[40]   Neurodegenerative disorders associated with diabetes mellitus [J].
Ristow, M .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (08) :510-529